Literature DB >> 14702200

Dendritic cells: sentinels against pathogens.

N P-Y Chung1, Y Chen, Vera S F Chan, P K H Tam, C-L S Lin.   

Abstract

Dendritic cells (DCs) are the most potent antigen-presenting cells, and are regarded as "natural adjuvants" for the induction of primary T or T-dependent immunity. DCs in the peripheral sites capture and process antigens. Encounter of exogenous or endogenous stimuli mature the function of DCs, and they thus acquire T-cell stimulatory capacity and distinct chemotactic behavior which enables them to migrate to lymphoid tissue. In the secondary lymphoid organs, they present antigens to T- and B-cells and stimulate their proliferation. Dendritic cells are also involved in tolerance induction, in particular, to self antigens. DCs also play a key role in the transmission of many pathogens, and therefore may become targets for designing new therapies. DCs have been manipulated in vitro and in vivo for cancer immunotherapy. In this article, we provide a concise overview of DC biology and its current and future role in clinical settings.

Entities:  

Mesh:

Year:  2004        PMID: 14702200     DOI: 10.14670/HH-19.317

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  5 in total

Review 1.  Potential functional role of plasmacytoid dendritic cells in cancer immunity.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Koji Arihiro
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

2.  Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.

Authors:  Jeffrey G Shannon; Dale Howe; Robert A Heinzen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

3.  Efficient activation of T cells by human monocyte-derived dendritic cells (HMDCs) pulsed with Coxiella burnetii outer membrane protein Com1 but not by HspB-pulsed HMDCs.

Authors:  Ying Wang; Xiaolu Xiong; Deping Wu; Xile Wang; Bohai Wen
Journal:  BMC Immunol       Date:  2011-09-03       Impact factor: 3.615

4.  Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.

Authors:  Samir Dalia; Michael Jaglal; Paul Chervenick; Hernani Cualing; Lubomir Sokol
Journal:  Cancers (Basel)       Date:  2014-11-14       Impact factor: 6.639

Review 5.  Herpes simplex virus interference with immunity: Focus on dendritic cells.

Authors:  Farías Ma; Duarte Lf; Tognarelli Ei; González Pa
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.